A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For ...
Medics in eastern Congo battle an ongoing Mpox outbreak while the region's chronic instability complicates public health ...
AllAfrica on MSN1d
Cholera and Mpox Cases Increasing Dangerously in DRC As Aid Cuts Push Health Systems to Near-Collapse [press release]Preventable diseases are sweeping the Democratic Republic of Congo (DRC). Cholera cases increased by 326, Mpox by 269, and measles by 95 people in North Kivu alone, during the last week of February, ...
On August 13, 2024, the Africa Centres for Disease Control and Prevention (Africa CDC) declared the multi-country mpox ...
"This study brought us a step forward in better understanding mpox disease and potential treatment strategies," said Jeanne ...
The Express Tribune on MSN2d
Mpox case in Khyber not locally transmittedPESHAWAR: The case of a woman who tested positive for mpox in Dogra, Khyber district of Khyber-Pakhtunkhwa, has not been ...
The NIH stopped recruiting for trials of tecovirimat against mpox after the drug was deemed not significantly more effective vs. placebo. Other antivirals against mpox are under development ...
Kampala: The cumulative number of laboratory-confirmed mpox cases in Uganda has reached 4,342, with 31 deaths reported since the outbreak was declared in the East African country eight months ago ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback